Radioimmunotherapy with Yttrium-90-Ibritumomab Tiuxetan as Part of a Reduced Intensity Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation in Patients with Advanced Indolent Non-Hodgkin Lymphoma: Interim Analysis of a Phase II Study.

ISSN
0006-4971
Date Issued
2008
Author(s)
Bethge, Wolfgang A.
Lange, Thoralf
von Harsdorf, Stephanie
Bornhauser, Martin
Federmann, Birgit
Stadler, Michael
Uharek, Lutz
Knop, Stefan
Dittmann, Helmut
Faul, Christoph
Vogel, Wichard
Kanz, Lothar
Bunjes, Donald W.